Uso de ocriplamina según la Asociación de cirujanos de Gran Bretaña y Eire

1 Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 2012;367(7): 606–615.

2 Kaiser PK, Kampik A, Kuppermann BD, Girach A, Rizzo S, Sergott RC. Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction. Retina 35(6): 1111–1127.

3 Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A et al. MIVI-TRUST Study Group. Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials.

Ophthalmology 2015; 122(1): 117–122.